Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FysioDanmark Bagsværd ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.1% 3.5% 7.8% 3.6% 3.4% 3.3% 4.3% 4.3%   Credit score (0-100)   68 54 31 51 53 48 48 48   Credit rating   BBB BBB BB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.1 0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,814 5,179 4,045 4,689 5,239 6,373 0.0 0.0   EBITDA   862 576 -697 490 913 1,714 0.0 0.0   EBIT   401 114 -1,258 -96.1 361 1,163 0.0 0.0   Pre-tax profit (PTP)   272.1 -2.3 -1,382.1 -281.3 162.0 822.3 0.0 0.0   Net earnings   208.3 -4.8 -1,082.0 -195.3 118.0 544.2 0.0 0.0   Pre-tax profit without non-rec. items   272 -2.3 -1,382 -281 162 822 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   333 234 892 1,706 1,516 1,327 0.0 0.0   Shareholders equity total   181 176 -906 -1,101 -983 -433 -483 -483   Interest-bearing liabilities   4,398 3,888 4,442 5,779 5,170 4,376 2,572 2,572   Balance sheet total (assets)   5,039 4,598 4,961 6,084 5,225 5,454 2,089 2,089   Net Debt   4,165 3,863 4,428 5,777 5,018 2,982 2,572 2,572     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,814 5,179 4,045 4,689 5,239 6,373 0.0 0.0   Gross profit growth   7.2% 35.8% -21.9% 15.9% 11.7% 21.6% -100.0% 0.0%   Employees   8 12 9 9 0 11 0 0   Employee growth %   60.0% 50.0% -25.0% 0.0% -100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,039 4,598 4,961 6,084 5,225 5,454 2,089 2,089   Balance sheet change%   -0.5% -8.7% 7.9% 22.6% -14.1% 4.4% -61.7% 0.0%   Added value   861.7 575.5 -697.4 490.2 947.3 1,714.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -891 -923 -265 -134 -1,104 -1,103 -1,327 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.5% 2.2% -31.1% -2.0% 6.9% 18.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   7.9% 2.4% -24.0% -1.5% 5.4% 19.2% 0.0% 0.0%   ROI %   8.5% 2.6% -28.9% -1.8% 6.5% 24.4% 0.0% 0.0%   ROE %   7.9% -2.7% -42.1% -3.5% 2.1% 10.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   3.6% 3.8% -15.4% -15.3% -15.8% -7.4% -18.8% -18.8%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   483.3% 671.3% -635.0% 1,178.5% 549.6% 174.0% 0.0% 0.0%   Gearing %   2,431.3% 2,207.8% -490.4% -524.8% -525.9% -1,010.8% -532.6% -532.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.8% 2.8% 3.0% 3.6% 3.6% 7.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.5 0.4 0.6 0.7 0.8 0.0 0.0   Current Ratio   0.6 0.5 0.4 0.6 0.7 0.9 0.0 0.0   Cash and cash equivalent   232.8 24.8 14.1 2.1 152.0 1,394.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -461.6 -684.8 -1,305.0 -878.8 -518.0 -332.4 -1,286.1 -1,286.1   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   108 48 -77 54 0 156 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   108 48 -77 54 0 156 0 0   EBIT / employee   50 9 -140 -11 0 106 0 0   Net earnings / employee   26 -0 -120 -22 0 49 0 0